Journal article · 2010 · Open access

Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands

Fahmideh Shabani, Lotf Ali Saghatforoush, Shahriar Ghammamy

Bulletin of the Chemical Society of Ethiopia, 24(2) · Published 26 May 2010 · DOI 10.4314/bcse.v24i2.54741

Open PDFView at the publisherCite this paper

In brief

“Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands” is a 2010 journal article by Fahmideh Shabani and 2 co-authors, published in Bulletin of the Chemical Society of Ethiopia. OpenAlex counts 48 citations as of 20 November 2026. It is open access: the full text is free to read at Bulletin of the Chemical Society of Ethiopia.

Citations
48
Most cited in
2023 (7)
Field-weighted impact
1.35
References
26
Authors
3

Abstract

The synthesis and characterization of two new iron(III) complexes, [Fe(pythsalI)]Cl2 and [Fe(pythsalBr)]Cl2 with the NSNO-donor tetradentate Schiff base ligands pythsalHX [(5–X-N-(2pyridylethylsulfanylethyl) salicylideneimine] (X = I, Br)) obtained from the inserted condensation of 1-(2-pyridyl)-3-thia-5-aminopentane with the respective derivative salicylaldehyde in a 1:1 molar ratio is reported. The iron(III) complexes were characterized by several techniques using elemental analysis (C, H, N), FT-IR, electronic spectra and molar conductance measurements. The elemental analysis data suggest the stoichiometry to be 1:2 [M:L] ratio formation. The molar conductance measurements reveal the presence of 1:2 electrolytic nature complexes. Infrared spectral data agreed with the coordination to the central metal ion through deprotonated phenolic oxygen, imine and pyridine type nitrogens and the thioether sulfur atoms. From ligand field spectral data an octahedral geometry is assigned to the iron(III) ion in all these complexes. These new compounds have showed anti-tumour activity against two kinds of cancer cells that are K562 (human chronic myeloid leukemia) and Jurkat (human T lymphocyte carcinoma). KEY WORDS: Iron(III) complexes, Tetradentate ligands, Unsymmetric Schiff base, NSNO-donor, Anti-tumour, K562, Jurkat Bull. Chem. Soc. Ethiop. 2010, 24(2), 193-199.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shabani, F., Saghatforoush, L. A., & Ghammamy, S. (2010). Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands. Bulletin of the Chemical Society of Ethiopia, 24(2). https://doi.org/10.4314/bcse.v24i2.54741

MLA 9

Shabani, Fahmideh, et al. “Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands.” Bulletin of the Chemical Society of Ethiopia, vol. 24, no. 2, 2010. https://doi.org/10.4314/bcse.v24i2.54741.

Chicago

Shabani, Fahmideh, Lotf Ali Saghatforoush, and Shahriar Ghammamy. 2010. “Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands.” Bulletin of the Chemical Society of Ethiopia 24 (2). https://doi.org/10.4314/bcse.v24i2.54741.

Harvard

Shabani, F., Saghatforoush, L. A. and Ghammamy, S. (2010) ‘Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands’, Bulletin of the Chemical Society of Ethiopia, 24(2). doi:10.4314/bcse.v24i2.54741.

IEEE

F. Shabani, L. A. Saghatforoush, and S. Ghammamy, “Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands,” Bulletin of the Chemical Society of Ethiopia, vol. 24, no. 2, 2010, doi: 10.4314/bcse.v24i2.54741.

BibTeX

@article{shabani2010synthesis,
  title     = {{Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands}},
  author    = {Shabani, Fahmideh and Saghatforoush, Lotf Ali and Ghammamy, Shahriar},
  journal   = {Bulletin of the Chemical Society of Ethiopia},
  year      = {2010},
  volume    = {24},
  number    = {2},
  doi       = {10.4314/bcse.v24i2.54741},
  url       = {https://doi.org/10.4314/bcse.v24i2.54741}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201711
201822
201922
202033
202122
202244
202377
202466
202522

Its field-weighted citation impact is 1.35: it has been cited 1.35 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties

  • iron(III) complexes
  • Schiff base ligands
  • salicylideneimine
  • antitumour activity
  • K562 cells
  • Jurkat cells
  • octahedral geometry
  • coordination chemistry

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Shabani, F., Saghatforoush, L. A., & Ghammamy, S. (2010). Synthesis, characterization and anti-tumour activity of iron(III) Schiff base complexes with unsymmetric tetradentate ligands. Bulletin of the Chemical Society of Ethiopia, 24(2). https://doi.org/10.4314/bcse.v24i2.54741

How many times has this paper been cited?

48 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Bulletin of the Chemical Society of Ethiopia: sign in and open the PDF from this page.

Who wrote this paper?

Fahmideh Shabani, Lotf Ali Saghatforoush, Shahriar Ghammamy.

What is the DOI of this paper?

10.4314/bcse.v24i2.54741, permanently at https://doi.org/10.4314/bcse.v24i2.54741. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.